| 26636/34351 | US=92 / Biol/Mol Povirk LF. DNA damage response, signalling pathways, and tumorigenesis: DNA-dependent protein kinase in repair, apoptosis, telomere maintenance, and chemotherapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 265-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ACABAR JUNTANDO RADIACAO; RUPTURAS DE FILAMENTOS DUPLOS; REPARO DO DNA; KU; ARTEMIS; REPARACAO FOCOS |
| 26637/34351 | US=92 / Biol/Mol Dent P, Curiel DT, Fisher PB. Resistance and sensitization: resistance/signaling pathways. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 281-98. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. RADIACAO; SINALIZACAO; QUINASE; FOSFATASE; ESPECIES REATIVAS DE OXIGENIO / NITROGENIO; RECEPTOR |
| 26638/34351 | US=92 / Biol/Mol Cabot MC. Resistance and sensitization: ceramide and multidrug resistance. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 299-312. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. CERAMIDA; QUIMIOTERAPIA; MULTIRRESISTENCIA; GLICOSILCERAMIDA SINTETASE |
| 26639/34351 | US=92 / Biol/Mol Smith DL, Nolden LK, Mills GB, Lu Y. Resistance and sensitization: chemo-and radiosensitization through inhibition of PI3K/Akt signaling. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 313-34. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. FOSFATIDILINOSITOL 3-QUINASE; AKT; SIGNALTRANSDUCTION; TERAPIA ALVO MOLECULAR; QUIMIOSSENSIBILIZACAO; RADIOSSENSIBILIZACAO |
| 26640/34351 | US=92 / Biol/Mol Allen GW, Harari PM. Resistance and sensitization: the advancement of epidermal growth factor receptor inhibitors in cancer therapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 335-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; RADIACAO; APOPTOSE; INIBIDORES DE MOLECULAS PEQUENAS; ANTICORPOS MONOCLONAIS |
| 26641/34351 | US=92 / Biol/Mol Houghton JA. Established cancer therapies: antimetabolites. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 361-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ANTIMETABOLITES; MORTE CELULAR; APOPTOSE; CATASTROFE MITOTICA; NECRESIS; SENESCENCIA |
| 26642/34351 | US=92 / Biol/Mol Sordet O, Pommier Y, Solary E. Established cancer therapies: topoisomerase I poisons and apoptotic topoisomerase I-DNA complexes. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 383-406. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 26643/34351 | US=92 / Biol/Mol Larsen AK, Skladanowski A. Established cancer therapies: perturbations of cellular functions by topoisomerase II inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 407-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TOPOISOMERASE II; AGENTES ANTICANCERIGENOS; DOXORRUBICINA; ETOPOSIDE; MORTE CELULAR; PARADA DO CRESCIMENTO; APOPTOSE; NECROSE; CATASTRIOHE MITOTICO; INDUZIDA POR DROGAS PSEUDOSENESCENCE; AUTOFAGIA |
| 26644/34351 | US=92 / Biol/Mol Woynarowski JM, Woynarowska BA. Established cancer therapies: the significance of poly-targeting in apoptosis induction by alkylating agents and platinum drugs. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 423-63. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. DNA DO ADULTO; DROGAS ALQUILACAO; DROGAS PLATIUM; ALQUILACAO DE PROTEINAS; TADGETING PROTEINA; REGULACAO REDOX |
| 26645/34351 | US=92 / Biol/Mol Klein LE, Horwitz SB. Established cancer therapies: contributions of apoptosis ana senescence to cytotoxicity produced by microtubule-stabilizing agents. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 465-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TAXOL; DISCODERMOLIDE; MICROTUBULOS ACELEROU A SENESCENCIA; AGENTES ESTABILIZADORES MIROTUBULE; APOPTOSE; CATASTROFE MITOTICA |
| 26646/34351 | US=92 / Biol/Mol Deininger M. Established cancer therapies: tyrosine kinase inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 477-508. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TERAPIA-ALVO; BCR-ABL; FLT3; EGFR; TYROSISE INIBITORS QUINASE; IMATINIB; GEFITINIB; ERLOTINIB; CANCER; LEUCEMIA |
| 26647/34351 | US=92 / Biol/Mol Furman RR, Leonard JP, Decter J, Coleman M. Recent and developing cancer therapies: monoclonal antibodies in lymphomas. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 511-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 26648/34351 | US=92 / Biol/Mol Doll JA, Hobbs JE, Soff GA. Recent and developing cancer therapies: role of apoptosis in anti-angiogenic cancer therapies. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 537-55. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ANGIOGENESE; APOPTOSE; THROMBOSPONDIN-1; CELULAS ENDOTELIAIS; ANTI-ANGIOGENICO |
| 26649/34351 | US=92 / Biol/Mol Oleinick NL, Morris RL, Nieminem AL. Recent and developing cancer therapies: photodynamic therapy-induced apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 557-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TERAPIA FOTODINAMICA; FOTOSSENSIBILIZADOR; MITOCONDRIA LISOSSOMO; RETICULO ENDOPLASMATICO; APOPTOSE |
| 26650/34351 | US=92 / Biol/Mol Fulda S, Debatin KM. Recent and developing cancer therapies: modulation of TRAIL signaling for cancer therapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 579-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 26651/34351 | US=93 / Biol/Mol Peek Junior RM. Infectious agents, cytokines, and cancer: helicobacter pylori and cytokines in the genesis of gastric cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 3-26. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. AGENTES INFECCIOSOS; CITOCINAS; CANCER; HELICOBACTER PYLORI; CITOCINAS NA GENESE DO CANCER GASTRICO |
| 26652/34351 | US=93 / Biol/Mol Lairmore M, Ratner L. Infectious agents, cytokines, and cancer: HTLV-1, cytokines, and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 27-51. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. |
| 26653/34351 | US=93 / Biol/Mol Jenkins FJ, Hensler HR. Infectious agents, cytokines, and cancer: herpesviruses, cytokines, and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 53-67. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. AGENTES INFECCIOSOS; CITOCINAS; CANCER; HERPESVIRUSES; CITOCINAS |
| 26654/34351 | US=93 / Biol/Mol DeWitte M, Shealy DJ, Nakada MT, Anderson GM. Cytokines and carcinogenesis: tumor necrosis factor and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 71-89. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. AGENTES INFECCIOSOS; CITOCINAS; CANCER; FATOR DE NECROSE TUMORAL |
| 26655/34351 | US=93 / Biol/Mol Bonine-Summers AR, Law BK, Moses HL. Cytokines and carcinogenesis: transforming growth factor-B and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 91-111. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. CITOCINAS; CARCINOGENESE; FATOR DE CRESCIMENTO TRANSFORMANTE-B; CANCER |